Arantza Sanvisens - Concepedia

Author

Arantza Sanvisens

Hospital Universitari Germans Trias i Pujol ORCID

Also Known As

A Sanvisens, A. SANVISENS, A. Sanvisens, A.S. Arantza Sanvisens, Amaia Onaindia-Agundez, Arantza Sanvisens, Arantza Sanvisens-Bergé, CohRTA study, Paola Zuluaga, Rafael Marcos-Gragera

110

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari Germans Trias i Pujol Universitat Autònoma de Barcelona Bellvitge University Hospital Universitat de Barcelona Institut Català d'Oncologia

About

Arantza Sanvisens is an author at Hospital Universitari Germans Trias i Pujol specializing in medicine, viral hepatitis, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	525
2	Epidemiology	4	4	222
3	Public Health	3	3	166
4	Health Sciences	2	2	46
5	Global Health	1	1	95

Arantza Sanvisens

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study Laura Botta, Gemma Gatta, Riccardo Capocaccia, The Lancet Oncology Cure Fraction EstimatesCancer EpidemiologyChildhood CancerMedicineCancer Management	2022	167
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study Roberta De Angelis, Elena Demuru, Paolo Baili, The Lancet Oncology Disease DurationEpidemiologyPopulation-based StudyCancer EpidemiologyCancer Risk	2024	95
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron, The Lancet HIV Primary ImmunodeficiencyTreatment And PreventionHuman RetrovirusImmunologyFirst-line Antiretroviral Therapy	2020	68
Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes Xavier Carrillo, Antonio Curós, Roberto Muga, European Heart Journal	2011	58
Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987–2001 Roberto Muga, Arantza Sanvisens, Ferrán Bolao, Drug and Alcohol Dependence Injection Drug UsersTreatment And PreventionViral HepatitisMetropolitan BarcelonaHepatitis	2006	47
Impact of Medical Comorbidity and Risk of Death in 680 Patients with Alcohol Use Disorders Inmaculada Rivas, Arantza Sanvisens, Ferrán Bolao, Alcoholism Clinical and Experimental Research	2013	43
Accuracy of Simple Biochemical Tests in Identifying Liver Fibrosis in Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis C Virus Cristina Tural, Jordi Tor, Arantza Sanvisens, Clinical Gastroenterology and Hepatology Liver FibrosisHepatologyHepatitis CViral HepatitisLiver Physiology	2008	41
Long-Term Mortality of Patients with an Alcohol-Related Wernicke–Korsakoff Syndrome Arantza Sanvisens, Paola Zuluaga, Daniel Fuster, Alcohol and Alcoholism	2017	40
Metabolic Syndrome among Individuals with Heroin use Disorders on Methadone Therapy: Prevalence, Characteristics, and Related Factors Gabriel Vallecillo, María José Robles, Marta Torrens, Substance Abuse	2017	40
Prevalence and associations of metabolic syndrome in patients with alcohol use disorder Anna Hernández‐Rubio, Arantza Sanvisens, Ferrán Bolao, Scientific Reports	2022	38

Page 1